US Stock MarketDetailed Quotes

CABA Cabaletta Bio

Watchlist
  • 2.290
  • +0.420+22.46%
Close Nov 25 16:00 ET
  • 2.350
  • +0.060+2.62%
Post 18:25 ET
111.93MMarket Cap-1060P/E (TTM)

About Cabaletta Bio Company

Cabaletta Bio, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in April 2017 and is headquartered in Philadelphia, PA.

Company Profile

SymbolCABA
Company NameCabaletta Bio
Listing DateOct 25, 2019
Issue Price11.00
Founded2017
CEODr. Steven Nichtberger,M.D.
MarketNASDAQ
Employees103
Fiscal Year Ends12-31
Address2929 Arch Street,Suite 600
CityPhiladelphia
ProvincePennsylvania
CountryUnited States of America
Zip Code19104
Phone1-267-759-3100
Websitehttp://www.cabalettabio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Steven Nichtberger,M.D.
  • Chairman of the Board, President and Chief Executive Officer
  • 4.81M
  • David J. Chang, M.D.,M.P.H.
  • Chief Medical Officer
  • 2.10M
  • Arun Das, M.D.
  • Chief Business Officer
  • --
  • Anup Marda, M.B.A.
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Gwendolyn K. Binder-Scholl, M.D.,PhD
  • President, Science and Technology
  • 2.34M
  • Shawn Cline Tomasello, M.B.A.
  • Independent Director
  • 509.94K
  • Dr. Scott C. Brun, M.D.
  • Independent Director
  • 255.83K
  • Mark Simon, M.B.A.
  • Independent Director
  • 260.15K
  • Catherine Bollard, M.D.
  • Independent Director
  • 255.43K
  • Richard C. Henriques, M.B.A.
  • Independent Director
  • 259.20K
  • Michael Gerard, J.D.
  • General Counsel and Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data